This invention relates to a device (10) for conditioning and applying a biphasic fluid cosmetic composition, comprising: a receptacle (12) extending along a main axis and defining an internal volume (30) able to receive said cosmetic composition, said receptacle comprising a neck (26) giving access to said internal volume; and a mixing member (42), received in the internal volume of the receptacle characterized in that: the mixing member includes a plurality of extended filaments (60), a first end (62) of each one of said filaments is connected to the neck of the receptacle, with the filaments being separated two-by-two by a non-zero distance (66) over at least 50% of a height (34) of the internal volume from said neck; and the mixing member is fixed in rotation with respect to the receptacle.

Compositions contain boron nitride nanomaterials at least partially coated with biomolecules.

Methods and systems for creating emulsions are described. Also described are the emulsions created by the methods or with the systems.

Methods and systems for creating emulsions are described. Also described are the emulsions created by the methods or with the systems.

Various embodiments include a method for determining the mixing ratio R of a fluid comprising a mixture of at least two different fluids for a technical process in a device comprising: irradiating an ultrasonic signal with a transmission level along a measuring distance running inside a measuring section; measuring a receiving level of the ultrasonic signal at one end of the measuring distance; determining an ultrasonic attenuation of the ultrasonic signal attenuated by the fluid based at least on the transmission and receiving levels of the ultrasonic signal; measuring a temperature of the fluid flowing through the measuring section; and determining a mixing ratio of the at least two different fluids from the determined ultrasonic attenuation and from the measured fluid temperature.

A highly stable cannabinoid nanoparticle carrier composition for administration to a human made by incorporating non-ionic surfactants with cannabinoid oils and lipids, sonicating for a predetermined period of time at a predetermined amplification with an ultrasonic liquid processor until completely integrated; combining the mixture with a carrier fluid that includes ascorbic acid and distilled water; and further sonicating the mixture using an ultrasonic liquid processor at predetermined amplitude for a predetermined period of time at a controlled temperature, and thereby to create a CBD nanoemulsion. The composition is tailored using non-ionic surfactants to adsorb to the surface of the cannabinoid oil particles to advantageously affect electrokinetics and surface forces at the interface of the bioactive cannabinoid particles and the suspending liquid are controlled by tailoring the suspending liquid to maximize the zeta potential.

A microfluidic device for forming droplets includes at least one ferrofluid reservoir disposed in the microfluidic device and containing a ferrofluid therein. The microfluidic device includes a continuous-phase reservoir disposed in the microfluidic device and containing an oil phase therein and one or more microfluidic channels connecting between the at least one ferrofluid reservoir and the continuous-phase reservoir, the continuous-phase reservoir comprising a step region having an increased height as compared to a height of the one or more microfluidic channels. To form droplets an externally applied magnetic field is applied to the device to pull the ferrofluid into the continuous-phase reservoir, whereby droplets are formed at step region.

A microfluidic device for forming droplets includes at least one ferrofluid reservoir disposed in the microfluidic device and containing a ferrofluid therein. The microfluidic device includes a continuous-phase reservoir disposed in the microfluidic device and containing an oil phase therein and one or more microfluidic channels connecting between the at least one ferrofluid reservoir and the continuous-phase reservoir, the continuous-phase reservoir comprising a step region having an increased height as compared to a height of the one or more microfluidic channels. To form droplets an externally applied magnetic field is applied to the device to pull the ferrofluid into the continuous-phase reservoir, whereby droplets are formed at step region.

A method of producing a pharmaceutical gel emulsion, wherein the emulsion is an oil-in-water gel emulsion, comprising the steps of forming an oil-in-water emulsion comprising at least one pharmaceutically acceptable oil, at least one aqueous phase, at least one osmotic agent, at least one emulsifying agent, mixing a gelling polysaccharide with the oil-in-water emulsion and allowing the resulting mixture to form the pharmaceutical gel emulsion, optionally mixing an bioactive agent into the pharmaceutical gel emulsion.

The present invention relates to a process of producing a nano Omega-3 microemulsion system includes: (i) preparing a dispersal phase by heating Omega-3; (ii) preparing a carrier by heating a liquid PEG (polyethylene glycol); (iii) adding the carrier to the dispersal phase; (iv) emulsifying as follows: when the temperature arrives at 60° C., adding ACRYSOL K-140 to the mixture of the carrier and dispersal phase in step (iii), continuing to stir at a speed of 500 to 700 rpm, at a temperature of 60 to 80° C., in vacuum, for 3 to 5 hours, controlling the quality of resulting product by dissolving into water and measuring the transparency, the reaction is quenched, the temperature is decreased slowly until it is in the range of 40 to 60° C.; emulsifying for the entire mixture for 30 minutes; (v) filtrating the product by injecting through nanofilter system before filling-packaging.